Healthcare stocks are higher with the NYSE Healthcare Sector
Index rising 0.5% and shares of healthcare companies in the S&P
500 climbing 0.6% as a group.
In company news, Staar Surgical (
) is up 18% to $12.40 a share, earlier climbing to a new 52-week
high of $12.93 after the maker of implantable eye lens raised its
guidance for FY13 revenue growth by 4% over its prior outlook, now
forecasting 12% to 14% growth.
Analysts, on average, are expecting 10.5% year-over-year sales
growth to around $70.5 million during the 12 months ending in
STAA also reported Q2 adjusted earnings of $0.05 per share, up
from $0.03 during the year-ago period and beating the consensus
view by $0.03 per share. Quarterly net sales jumped 14% to $18.2
million, also exceeding the Street view by around $820,000.
The Q2 results $11.3 million in sales of the company's Visian
ICL product portfolio, which posted a 31% year-over-year
In other sector news,
(+) ANIK, (+20%, hit fresh year highs) Reports Q2 net income of
$0.40 per share, topping analyst estimates by $0.17 per share.
Total revenue rose 6% year over year to $20.8 million, topping the
Street view by $3.71 million.
(-) GHDX, (-2.1%) Q2 net loss of $0.10 per share trails analyst
expectations by $0.02. Revenue was up 11.4% over last year to $63.7
million, matching estmates.
Copyright (C) 2013 MTNewswires.com. All rights reserved. Unauthorized reproduction is strictly prohibited.